Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The main purpose of this research study is to determine whether the drug Levetiracetam
(Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™)
has been approved for the treatment of seizures by the U.S. Federal Food and Drug
Administration (FDA) and is available by prescription. Levetiracetam has not been approved by
the FDA for the treatment of panic disorder.